X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (1415) 1415
humans (1403) 1403
pregnancy (1218) 1218
oxytocics - therapeutic use (925) 925
adult (594) 594
index medicus (572) 572
obstetrics & gynecology (512) 512
oxytocin - therapeutic use (428) 428
oxytocics (401) 401
oxytocics - administration & dosage (382) 382
misoprostol - therapeutic use (363) 363
misoprostol (321) 321
oxytocin (319) 319
postpartum hemorrhage - prevention & control (307) 307
ergot alkaloids - therapeutic use (272) 272
cardiovascular agents (230) 230
oxytocics - adverse effects (220) 220
postpartum hemorrhage (216) 216
labor, induced - methods (199) 199
labor, induced (188) 188
oxytocics - pharmacology (188) 188
misoprostol - administration & dosage (184) 184
oxytocin - administration & dosage (177) 177
young adult (169) 169
labor, obstetric (159) 159
treatment outcome (157) 157
hemorrhage (156) 156
cesarean section (149) 149
administration, intravaginal (147) 147
labor (147) 147
animals (146) 146
obstetrics and gynecology (145) 145
time factors (131) 131
dinoprostone - therapeutic use (128) 128
management (125) 125
misoprostol - adverse effects (122) 122
prospective studies (122) 122
prevention (118) 118
double-blind method (116) 116
male (111) 111
infant, newborn (110) 110
cervical ripening (107) 107
pregnancy outcome (106) 106
labor stage, third (104) 104
women (104) 104
3rd stage (102) 102
risk factors (101) 101
uterine contraction - drug effects (100) 100
adolescent (99) 99
oxytocin - pharmacology (99) 99
oral misoprostol (98) 98
labor induction (95) 95
pharmacology & pharmacy (95) 95
postpartum hemorrhage - drug therapy (94) 94
abridged index medicus (91) 91
medicine, general & internal (89) 89
pituitary hormones (87) 87
retrospective studies (86) 86
delivery, obstetric (82) 82
oxytocin - adverse effects (82) 82
dinoprostone - administration & dosage (79) 79
cervical ripening - drug effects (78) 78
obstetrics (76) 76
administration, oral (75) 75
middle aged (75) 75
maternal mortality (74) 74
randomized controlled-trial (74) 74
dose-response relationship, drug (73) 73
health aspects (72) 72
analysis (70) 70
oxytocin - analogs & derivatives (70) 70
parity (70) 70
childbirth (69) 69
postpartum hemorrhage - therapy (67) 67
rats (67) 67
anesthesiology (65) 65
randomized controlled trials as topic (63) 63
postpartum period (62) 62
childbirth & labor (60) 60
pregnant women (60) 60
dinoprostone (58) 58
cervix uteri - drug effects (57) 57
cesarean delivery (57) 57
delivery (57) 57
gestational age (57) 57
prostaglandins (56) 56
trial (56) 56
ergonovine - therapeutic use (54) 54
uterus (54) 54
delivery, obstetric - methods (53) 53
term (53) 53
double-blind (52) 52
reproductive biology (51) 51
postpartum hemorrhage - epidemiology (50) 50
research (50) 50
risk (50) 50
uterus - drug effects (50) 50
usage (49) 49
active management (48) 48
care and treatment (48) 48
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1382) 1382
French (75) 75
German (62) 62
Spanish (49) 49
Italian (25) 25
Bulgarian (19) 19
Russian (12) 12
Chinese (6) 6
Czech (5) 5
Portuguese (5) 5
Danish (4) 4
Polish (4) 4
Swedish (3) 3
Finnish (2) 2
Hungarian (2) 2
Japanese (2) 2
Hebrew (1) 1
Norwegian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
American Journal of Obstetrics and Gynecology, ISSN 0002-9378, 2016, Volume 215, Issue 6, pp. 704 - 711
Genitourinary syndrome of menopause, a new term for a condition more renowned as atrophic vaginitis, is a hypoestrogenic condition with external genital,... 
Obstetrics and Gynecology | urogenital atrophy | vulvovaginal atrophy | nonhormonal vaginal therapy | atrophic vaginitis | dyspareunia | quality of life | estrogen-progestin therapy | hypoestrogenism | urinary incontinence | genitourinary syndrome of menopause | menopausal hormone therapy | vaginal maturation index | SELECTIVE ESTROGEN COMPLEX | SEXUAL HEALTH | LASER THERAPY | LASOFOXIFENE | OBSTETRICS & GYNECOLOGY | BONE LOSS | URINARY-TRACT | QUALITY-OF-LIFE | POSTMENOPAUSAL WOMEN | VULVO-VAGINAL ATROPHY | Atrophic Vaginitis - metabolism | Dyspareunia - physiopathology | Life Style | Humans | Menopause | Vulvar Diseases - therapy | Atrophic Vaginitis - diagnosis | Vulvar Diseases - metabolism | Vulvar Diseases - diagnosis | Selective Estrogen Receptor Modulators - therapeutic use | Urinary Incontinence - metabolism | Female | Oxytocics - therapeutic use | Lubricants - therapeutic use | Atrophic Vaginitis - physiopathology | Low-Level Light Therapy - methods | Urinary Incontinence - physiopathology | Urinary Incontinence - diagnosis | Atrophic Vaginitis - therapy | Dehydroepiandrosterone - therapeutic use | Urinary Incontinence - therapy | Syndrome | Dyspareunia - therapy | Estrogen Replacement Therapy - methods | Quality of Life | Vulvar Diseases - physiopathology | Oxytocin - therapeutic use | Dyspareunia - diagnosis | Dyspareunia - metabolism | Medical colleges | Lasers in surgery | Lubrication and lubricants | Estrogen | Development and progression | Postmenopausal women | Diseases | Homeopathy | Materia medica and therapeutics | Lasers in medicine | Dehydroepiandrosterone | Causes and theories of causation
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 12/2018, Volume 2018, Issue 12, p. CD011689
Journal Article